Blood test could tell doctors if cancer treatment is working
NCT ID NCT04790682
Summary
This study aims to see if simple blood tests can predict how well immunotherapy will work for people with advanced lung cancer. Researchers will track 300 patients receiving first-line immunotherapy, taking regular blood samples to look for cancer DNA and immune cell changes. The goal is to find early signs in the blood that show whether the treatment is working, which could help doctors make better treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hopital Ambroise Pare
RECRUITINGBoulogne-Billancourt, 92100, France
Contact
Contact
-
Institut Curie
RECRUITINGParis, 75005, France
Contact
Contact
-
Institut Curie
RECRUITINGSaint-Cloud, 92210, France
Contact
Contact
Conditions
Explore the condition pages connected to this study.